 The stock price of Henry Schein, a healthcare products and services distributor, has seen a 12 rise in a month, while it is up a solid 30 in a year. The company reported upbeat Q4 results last month, with revenue of 3.3 billion and adjusted EPS of 1.07, beating the consensus estimates. 